#USA #New York #Charles C. Foti #Kahn Swick #Inspire Medical

Kahn Swick & Foti's Investigation into Inspire Medical Systems

On February 13, 2026, Kahn Swick & Foti, LLC, a prominent law firm led by former Louisiana Attorney General Charles C. Foti, Jr., announced the initiation of an investigation into Inspire Medical Systems, Inc. (NYSE: INSP). The investigation follows troubling reports regarding Inspire's Inspire V device launch, which has revealed significant operational and compliance issues.

The Background of the Investigation

In August 2025, Inspire Medical Systems had conveyed assurance to stakeholders that it was fully prepared to launch its Inspire V device. However, they later disclosed that the rollout was facing extensive delays due to unforeseen complications. These included widespread failure among various medical centers to complete necessary training and onboarding protocols before proceeding with purchases and implementations of the Inspire V device. Furthermore, software updates for claims processing were not set to take effect until mid-July, further complicating matters.

Adding to the company's woes, it was reported that an excess inventory situation had created a gap between supply and demand for the Inspire V device. As a result, management took the unprecedented step of slashing the company's earnings guidance for 2025 by an alarming 80%. The adjustment reduced expected earnings per share from an earlier estimate of between $2.20 and $2.30 down to just $0.40 to $0.50 per share.

These discrepancies raised eyebrows among investors and triggered a securities class action lawsuit against the company. The lawsuit alleges that Inspire Medical’s executives failed to disclose critical information that could have impacted shareholders' decisions, potentially violating federal securities laws.

Focus of the Investigation

The focus of KSF's investigation will be to uncover whether the officers and directors of Inspire Medical Systems violated their fiduciary responsibilities towards shareholders. This inquiry will seek to determine if there was any malfeasance or breach of state or federal laws concerning the operations and disclosures made by the company. Such an investigation is crucial for maintaining shareholder trust and transparency in corporate governance, especially in a healthcare sector that is increasingly scrutinized for ethical compliance.

If you have relevant information regarding Inspire Medical or have held shares for an extended period, you are encouraged to reach out to KSF without obligation. Interested individuals can contact the firm at 1-833-938-0905 or email Lewis Kahn directly. More information about the investigation can also be found by visiting KSF's official website.

About Kahn Swick & Foti, LLC

Kahn Swick & Foti, LLC is highly regarded as one of the leading boutique law firms focusing on securities litigation. With numerous accolades, including recognition for achieving significant settlements in class action cases, the firm represents a diverse client base—from institutional investors to individual stakeholders—who have suffered losses in investments due to corporate misconduct. With offices in several major U.S. cities and a representative office in Luxembourg, KSF continues to emphasize accountability and recovery for those affected by corporate fraud.

Conclusion

As the investigation unfolds, it highlights the importance of adherence to transparency and regulatory standards in publicly traded companies, particularly in sectors that directly impact public health. Kahn Swick & Foti's commitment to seeking justice for shareholders signals a robust response against potential corporate malpractice and reassures investors of vigilant oversight in the medical technology field.